Clinical Trials for ALK-positive Advanced NSCLC

Find clinical trials for alk-positive advanced nsclc. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma ：A Multicenter, Real-World Clinical Study

NCT ID: NCT06785584

This clinical trial is investigating the use of a medication called ensartinib as a neoadjuvant therapy for patients with operable or potentially operable ALK-positive lung adenocarcinoma, which is...

Not yet recruiting

Phase: PHASE4 Type: interventional Locations: Fuzhou, Fujian, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions